Alembic Pharmaceuticals acquires UTILITY therapeutics
Pharmaceutical Technology
JULY 7, 2025
How will RFK Jr’s American dream for vaccines play out? The most common adverse reactions are diarrhoea, nausea, vulvovaginal candidiasis, genital pruritus and headache. Alembic plans to make Pivya available in the US in the fourth quarter of 2025.” ” Pivya has been proven safe in three studies.
Let's personalize your content